Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Genfit S.A. ADR (GNFT)

Genfit S.A. ADR (GNFT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genfit S.A. ADR PARC EURASANTE 885 AVENUE EUGENE AVINEE LOOS I0 59120 FRA

www.genfit.com P: 33-3-20-16-40-00 F: +33 220164001

Description:

Genfit SA is a biopharmaceutical company. It focuses on the discovery and development of therapeutic and diagnostic solutions in metabolic and liver related diseases. The company's lead products include Elafibranor, Nitazoxanide and TGFTX1 which are in clinical stage. Genfit SA is based in Loos, France.

Key Statistics

Overview:

Market Capitalization, $K 171,931
Enterprise Value, $K 107,191
Shares Outstanding, K 49,835
Annual Sales, $ 41,320 K
Annual Net Income, $ -31,270 K
Last Quarter Sales, $ 14,265 K
EBIT, $ 0 K
EBITDA, $ -26,980 K
60-Month Beta 1.08
% of Insider Shareholders 4.20%
% of Institutional Shareholders 2.24%
Float, K 47,742
% Float 95.80%
Short Volume Ratio 0.06

Growth:

1-Year Return -5.68%
3-Year Return -19.77%
5-Year Return -85.41%
5-Year Revenue Growth 366.89%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 04/11/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GNFT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 6.21
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -75.68%
Debt/Equity 0.26
Price/Sales 4.21
Price/Cash Flow N/A
Price/Book 2.33
Book Value/Share 1.48
Interest Coverage -4.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar